mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.6 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |